Heartseed Inc. (TSE: 219A)
Health Care · Biotechnology · JP
¥1,940.00
+2.54% today · -48.3% 1Y
Heartseed Inc. (TSE: 219A) operates in the Biotechnology industry within the Health Care sector. The company is valued at $278.87M and employs 43 people.
Over the last twelve months the share price has lost 48.3%, trading between 1.34K and 3.92K.
Tweenvest scores Heartseed Inc. across four factors: quality 43/100, value 47/100. Its strongest factor is value.
219A price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $278.87M
- Revenue (TTM)
- $19.64M
- P/E
- 75.46
- EPS
- 25.71
- Dividend yield
- —
- Beta (5Y)
- -0.85
- 52-week high
- ¥3,925.00
- 52-week low
- ¥1,343.00
- Avg volume (3M)
- —
- Shares outstanding
- 22.87M
- Employees
- 43
- Next earnings
- —
About Heartseed Inc.
Headquartered in Tokyo, Japan, Heartseed, Inc. was established on November 30, 2015, by Keiichi Fukuda, Takumi Akiyama, Toshiharu Furukawa, and Yutaro Kasai. The company specializes in the development and advancement of cardiac regenerative medicine.
- ISIN
- JP3765140003
- Founded
- 2015
- Listed since
- Jul 30, 2024
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.03 | -1.79% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $441.19 | -0.24% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.67 | -0.07% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $549.12 | -0.67% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $820.43 | -1.58% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $145.92 | -8.13% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.